Journal article
Problems and solutions to filling the drying drug pipeline for psychiatric disorders: A report from the inaugural 2012 CINP Think Tank
B Dean, HJ Moller, TH Svensson, MA Geyer, D Rujescu, E Scarr, MJ Millan
International Journal of Neuropsychopharmacology | Published : 2014
Abstract
The inaugural Collegium Internationale Neuro-Psychopharmacologicum (CINP) Think Tank, a small open meeting sponsored by the CINP, discussed impediments to developing new drugs for psychiatric disorders and approaches to overcome these impediments. Whilst neuropsycharmacology has a rich pharmacopeia (current treatments benefiting many individuals), issues of treatment resistance, sub-optimal response and unwanted side effects remain problematic. Many scientific, economic and social issues are impeding the development of drugs (e.g. higher risk of failure, placebo effects, problematic regulatory environments, pressures imposed by patent protection, downward pressure on reimbursements and finan..
View full abstractGrants
Awarded by National Institute on Drug Abuse
Funding Acknowledgements
The authors wish to acknowledge the commitment of the CINP to stimulating dialogue on important issues relating to the field of neuropsychopharmacology by acting as the sole sponsor of the inaugural CINP Think Tank. The authors would also like to thank Andrew Gibbons, Angelos Halaris, Amir, Kalali, Wolfgang Maier, Vincenzo Micale, Andrea Schimitt, Christian Schutz, Alexandra Sulcove and Chris Turk for being contributors to the discussions and debates at the Think Tank.